The Epigenetic Therapeutic Target Summit is the first-ever industry forum dedicated exclusively to the frontier of drug development in epigenetics.

The two-day program will enable you to:

  • Explore the full spectrum oncological and non-oncological applications of genetic regulation therapeutics that is being investigated to identify new unmet clinical needs that epigenetics could be central to treating.
  • Evaluate therapeutic targets including LSD1, HDAC, KAT6, H2AThr120 and Non-Coding RNA. This broad array of new and old is bringing some exciting novel insights to this growing meeting of genetic specialists.
  • Network with the leading biopharma companies and academic institutions in this space with over 4 hours of 1-to-1 networking time, interactive panels and over a dozen keynote presentations.
  • Delve into the nitty-gritty challenges faced from preclinical to clinical development alongside a group of peers with our new Pre-Conference Workshop. Effectively improve your drug development route and expand your research to identify new opportunities.

If you are investing clinical development resources into epigenetic therapeutics, this online forum has been created with you in mind and will connect you with pharma, biotechs, academia and solution providers accelerating drug candidates towards the goal of a functional cure.

Don’t just take it from us, hear what people have already had to say about our agenda and speaker line-up:

“A very good, varied and interesting program”

Storm Therapeutics 

“I particularly like the opening keynote, referencing precision”

Bristol-Myers Squibb 

“A great agenda for the epigenetics community”

Constellation Pharmaceuticals